Today we announced the promotion of Samir Siddhanti to Chief Business Officer and a member of the company's executive Management Committee. He will lead our enterprise growth strategy, overseeing business development, corporate strategy, alliance management and program management.

https://neurocrine.gcs-web.com/news-releases/news-release-details/neurocrine-biosciences-appoints-samir-siddhanti-chief-business